| Krupali Patel, DMD | |
|
352 Cooley St, Springfield, MA 01128-1144 | |
| (413) 285-7283 | |
| Not Available |
| Full Name | Krupali Patel |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 352 Cooley St, Springfield, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083213417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | DN1858845 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Krupali Patel, DMD 352 Cooley St, Springfield, MA 01128-1144 Ph: (413) 285-7283 | Krupali Patel, DMD 352 Cooley St, Springfield, MA 01128-1144 Ph: (413) 285-7283 |
News Archive
PureWellness, Inc., a leading provider of online wellness solutions, announced it has signed agreements with three new hospitals; Northeast Georgia Health Systems, McCullough-Hyde Memorial Hospital, and Fletcher Allen Health Care.
The total impact of HIV treatment in the US has been evaluated for the first time. Dr. Rochelle Walensky, ( Harvard Medical School in Boston), speaking at the 12th Annual Retrovirus Conference, quoted from research which estimated the survival benefits of highly active antiretroviral therapy (HAART) and opportunistic infection prophylaxis in the US from 1989 to 2003.
OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.
Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall survival compared with those who had more than minimal residual invasive disease at surgery following presurgery chemotherapy, according to results from the randomized phase II CALGB/Alliance 40603 clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.
› Verified 3 days ago
Dr. Peter Antonopoulos, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1655 Boston Rd, Suite 168, Valley Dental Associates, Springfield, MA 01129 Phone: 413-543-2101 | |
Dr. Steven Edward Burison, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3455 Main St Ste 102, Springfield, MA 01107 Phone: 413-733-9490 | |
Isha Sood, Dentist Medicare: Medicare Enrolled Practice Location: 1795 Main St Ste 101, Springfield, MA 01103 Phone: 413-737-9548 | |
Dr. Gerard Joseph Thibault, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 43 Sullivan St, Springfield, MA 01104 Phone: 413-785-5566 Fax: 413-785-5568 | |
Dr. Michael David Caban, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1795 Main St, #109, Springfield, MA 01103 Phone: 413-734-4443 | |
Dr. Robert J Koolkin, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1795 Main St, Suite 116, Springfield, MA 01103 Phone: 413-734-9400 | |
Thaida Duong, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 532 Sumner Ave, Springfield, MA 01108 Phone: 413-739-1100 Fax: 413-737-3608 |